The Brockman Medical Research Foundation has provided support for research being conducted by Dr. Jan-Ake Gustafsson and his team at the Center for Nuclear Receptors and Cell Signalling at the University of Houston.
Dr. Gustafsson is the Founding Director of the Center, as well as the Robert A. Welch Professor in the Department of Biology and Biochemistry at the university.
The Center’s focus is on cell signalling in cancer (of the prostate, breast, pancreas, lung and cervix), neurodegenerative diseases, and immunotherapy for cancer.
Since its creation in 2009, the Center has become nationally recognised for its scientific advances in the areas of prostate cancer, diabetes, degenerative neurological diseases, and cancer immunotherapy.
Working from the Center’s world-class labs, researchers combine interdisciplinary research and dynamic collaboration with the Texas Medical Center and industry partners.
The grant by the Brockman Medical Research Foundation supports the conduct of research, basic and clinical, into a new approach for the treatment of prostate cancer utilising an estrogenic receptor-Beta agonist.
- Project Focus: Cell signalling in cancer